Search Result "FDA-approved inhibitors"
FDA Approval for Phytochemicals in the Treatment of Cancer
Ebook: Phytonutrients in the Treatment of Gastrointestinal Cancer
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815049633123010006
Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023
Journal: Current Topics in Medicinal Chemistry
Volume: 24 Issue: 10 Year: 2024 Page: 843-849
Author(s): Andrew A. Bolinger
US-FDA Approved Drugs in 2020 and 2021: A Review
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 23 Issue: 12 Year: 2023 Page: 1273-1297
Author(s):
Syntheses of FDA Approved Integrase Inhibitor HIV Drugs and Improved Manufacturing using Flow Processing
Ebook: Frontiers in Clinical Drug Research: HIV
Volume: 4 Year: 2019
Author(s): Omobolanle Janet Jesumoroti,Faith Akwi,Paul Watts
Doi: 10.2174/9781681085265119040005
A Systematic Analysis of Physicochemical and ADME Properties of All Small Molecule Kinase Inhibitors Approved by US FDA from January 2001 to October 2015
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 29 Year: 2017 Page: 3159-3184
Author(s): Zhihong O`Brien,Mehran F. Moghaddam
Biosimilars Regulation in the United States and FDA Approved Biosimilars from 2015-2018
Journal: Applied Clinical Research, Clinical Trials and Regulatory Affairs
Volume: 7 Issue: 1 Year: 2020 Page: 12-29
Author(s): Vikram,Aakash Deep,Manita,Avtar C. Rana,Monu Yadav,Rakesh K. Marwaha
Commercially Available, FDA-approved Epigenetic Modifiers As Therapeutic Agents in Bacterial Infection
Journal: Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued)
Volume: 2 Issue: 1 Year: 2015 Page: 79-88
Author(s): Pádraic J. Dunne,Georgia Richard,Joseph Keane
FDA-approved Drugs Selected Using Virtual Screening Bind Specifically to G-quadruplex DNA
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 12 Year: 2013 Page: 2164-2173
Author(s): Daimel Castillo-Gonzalez,Gisselle Perez-Machado,Aurore Guedin,Jean-Louis Mergny,Miguel-Angel Cabrera-Perez
In Vitro Screening of an FDA-Approved Library Against ESKAPE Pathogens
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 14 Year: 2017 Page: 2147-2157
Author(s): Waleed Younis,Ahmed AbdelKhalek,Abdelrahman S. Mayhoub,Mohamed N. Seleem
Revealing Potential Binding Affinity of FDA Approved Therapeutics Targeting Main Protease (3CLpro) in Impairing Novel Coronavirus (SARSCoV- 2) Replication that Causes COVID-19
Journal: Coronaviruses
Volume: 1 Issue: 1 Year: 2020 Page: 98-107
Author(s): D. Sivaraman,P.S. Pradeep,S. Sundar Manoharan,C. Ramachandra Bhat,K.V. Leela,V. Venugopal